Batroxobin for Prevention of Restenosis in Diabetic Patients After Infrapopliteal Arterial Angioplasty: A Small Randomized Pilot Trial

This pilot trial revealed that batroxobin usage was effective in preventing restenosis and reocclusion after infrapopliteal arterial angioplasty, and it might provide better clinical symptoms relief; however, it did not report preferable limb salvage or amputation-free rates.